Mmmmm, fresh genome. This is a peek at the nanopore data ahead of Illumina run next week. Amazingly fast turnaround time of TWO DAYS. Thanks, @plasmidsaurus!!! Already designing knockout cassettes as we speak. Engineering microbes for nice smells at @SenseoryPlants.
Hanlee Ji and team are unlocking the mutational landscape of cancer at single-cell resolution. From BCL2 fusions to KRAS mutations — read how they’re revealing more about tumour heterogeneity: https://t.co/9tKet2R6UG
Excited to share our new study of #genomics🧬, #EHR📈 + treatment outcomes of 78K patients across 20 #cancers!
We identified >700 mutations predicting which drugs💊 are effective for individual patients. Our #ML model predicts who respond well to immunotherapy #precisioncancer
Nice. I remember doing a BBSRC summer internship in the UK on wheat varieties and the affect of take-all on them....both by hand, visual scoring, and a few basic molecular techniques...! 🤣
How times have changed in Ag!
Scientists from the Earlham Institute will head to #PAG32 next month, presenting their work during the '#wheatgenomics to breeding' session on using #genomeassemblies and ultra-long #Nanopore reads to identify key variations in wheat.
https://t.co/wf4BxqC0jP
Excited to show our latest attempt at a clinically meaningful clinical cancer genome with rapid turn around (24 hours!) times using Oxford Nanopore sequencing technology for patients who need a rapid, whole genome assessment of their tumour and germline, offering them (1/n):
PromethION 2 Integrated (P2i) is moving to open early access.
With its onboard compute and integrated screen, the self-contained device is bringing high-quality, real-time sequencing to a wider range of labs.
Learn more: https://t.co/8rEKIWSuhV #WYMM
Direct RNA sequencing update!
We are pleased to announce that RNA004 is moving into open Early Access.
RNA004 provides higher outputs and accuracy compared to the previous version RNA002.
Learn more: https://t.co/5duflxkl9P 1/9
Well here's the @nanopore update.. we have carried out a hereditary cancer panel screen:
* ~200 genes
* 15mbases panel
* Coverage between 50-70x on target; 5x off target
* 16hr run time LSK114 + R10.4.1
This is PMS2 exon 10&11 - a notoriously difficult place to sequence with SR
I am happy to say that as a result of direct support from the Brenton group, we now have an Oxford @nanopore PromethION 24 housed within the genomics core at @CRUK_CI!
Looking forward to see what we can discover with this technology